Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

FibroGen, Inc - Common Stock (NQ:FGEN)

9.710 UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about FibroGen, Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 54 companies hit new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  During Thursday's session, 40 stocks hit new 52-week lows. 
Via Benzinga
News headline image
FibroGen Shares Are Tumbling After Another Pamrevlumab Trial Setback ↗
FibroGen Inc (NASDAQ: FGEN) shares are trading lower after the company 
Via Benzinga
News headline image
FibroGen's Return on Invested Capital Overview ↗
 
Via Benzinga
News headline image
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
Down 80% in 1 Day, Is There Any Hope for FibroGen Stock? ↗
Its pipeline is looking thin, and it might hit another speed bump quite soon. 
Via The Motley Fool
News headline image
Stock Market Rally Roars Back Toward Highs; Carnival, Delta, Micron, Nvidia In Focus: Weekly Review ↗
Major indexes rebounded strongly and many stocks flashed buy signals. 
Via Investor's Business Daily
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 27, 2023 ↗
 
Via Benzinga
News headline image
INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Fibrogen, Inc. and Encourages Investors With Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
Dow Surges Over 50 Points; Avalo Therapeutics Shares Plummet ↗
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining more than 50 points on Monday. The Dow traded up 0.18% to 33,788.05 while the NASDAQ fell 0.61% to 13,410.63. The S&P 500,... 
Via Benzinga
News headline image
Analyst Downgrades FibroGen On Questions Regarding Future Direction ↗
Earlier today, FibroGen Inc (NASDAQ: FGEN) said its Phase 3 ZEPHYRUS-1 trial of pamrevlumab in idiopathic pulmonary fibrosis (IPF) did not meet the primary endpoint of change in forced vital capacity... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Stocks Modestly Lower; Dow Looks To Extend Losing Streak ↗
Stocks are modestly below breakeven this afternoon. 
Via Talk Markets
News headline image
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against FibroGen, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
Crude Oil Rises; Carnival Shares Drop After Q2 Results ↗
U.S. stocks traded lower midway through trading, with the Nasdaq dropping around 80 points on Monday. The Dow traded down 0.02% to 33,719.54 while the NASDAQ fell 0.53% to 13,420.67. The S&P 500, also... 
Via Benzinga
News headline image
Is the Stock Market Closed on the Fourth of July 2023? ↗
Investors are looking for information about the stock market being closed on the Fourth of July and we've got the answers they seek! 
Via InvestorPlace
News headline image
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023 ↗
 
Via Benzinga
News headline image
Is the Stock Market Closed on July 3, 2023? ↗
Investors are preparing for Independence Day and that has some traders wondering if the stock market is closed on July 3, 2023. 
Via InvestorPlace
News headline image
Insiders Promise Not to Sell AMTD Digital (HKD) Stock Until 2025 ↗
AMTD Digital (HKD) stock is on the move Monday after insiders promised not to sell shares on the public market for a few more years. 
Via InvestorPlace
News headline image
Why Is FibroGen (FGEN) Stock Down 81% Today? ↗
FibroGen (FGEN) stock is heading lower on Monday after the company's Phase 3 clinical trial failed to meet its primary endpoint. 
Via InvestorPlace
News headline image
FibroGen Crashes To Its Lowest-Ever Point On A Second Failure For Its Lead Drug ↗
This is the company's second high-profile failure this month. 
Via Investor's Business Daily
News headline image
US Stocks Edge Higher; Goldman Sachs Downgrades Tesla To Neutral ↗
U.S. stocks traded slightly higher this morning, with the Dow Jones gaining around 25 points on Monday. Following the market opening Monday, the Dow traded up 0.08% to 33,753.64 while the NASDAQ rose... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for... 
Via Benzinga
News headline image
FibroGen Stock Plunges Under Key Lines As Lead Drug Fails; Why Hope Isn't Lost ↗
The company's lead drug didn't improve upper-limb mobility for some patients with the disease. 
Via Investor's Business Daily
News headline image
FibroGen's One Study For Duchenne Muscular Dystrophy Fails To Hit Main Goal ↗
FibroGen Inc (NASDAQ: FGEN) announced topline data from the Phase 3 LELANTOS-1 trial of pamrevlumab for the treatment of non-ambulatory patients with Duchenne Muscular Dystrophy (DMD)  
Via Benzinga
News headline image
FibroGen Stock Joins Rank Of Stocks With RS Ratings Over 90 ↗
On Tuesday, FibroGen stock saw a positive improvement to its Relative Strength Rating, rising to 94 from 90 a day earlier. 
Via Investor's Business Daily
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2023 ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.